Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical niosomal zinc sulfate for cutaneous leishmaniasis
IRCT20170806035524N4Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of zinc in cutaneous leishmaniasis (CL), sponsored by Kerman University of Medical Sciences. Started Jan 2018; status: completed.
02
Drugs
zinc
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT20170806035524N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170806035524N4.